Adial Pharmaceuticals (Nasdaq: Adil) company information, Employees & Contact Information

Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show Yahoo Finance

Aired in 175 countries: Adial CEO Cary Claiborne Featured on Big Biz Show, Available via Cable, Streaming and Radio Stock Titan

Adial Pharmaceuticals Files Update to Provisional Patent Application for AD04, Enhancing Intellectual Property Protection through 2045 | ADIL Stock News Quiver Quantitative

Adial Pharmaceuticals Signs Agreements with Cambrex and Thermo Fisher for AD04 Drug Production and FDA Submission Nasdaq

Adial Pharmaceuticals Receives Positive Response from FDA GlobeNewswire

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04 Yahoo Finance

Adial's Genetic-Targeted Alcohol Treatment Heads to Phase 3 After FDA Green Light Stock Titan

Adial Pharmaceuticals Announces Positive FDA Feedback on AD04 Phase 3 Trial Design for Alcohol Use Disorder Quiver Quantitative

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply Yahoo Finance

Adial Pharmaceuticals Secures 20+ Years of Patent Protection for Revolutionary Alcohol Use Disorder Drug Stock Titan

Adial Pharmaceuticals Receives 180-Day Extension to Regain Nasdaq Compliance with Minimum Bid Price Requirement Quiver Quantitative

Nasdaq Grants Biotech Adial Pharmaceuticals Final 180-Day Extension to Maintain Market Listing Stock Titan

Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting Yahoo Finance

Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration Stock Titan

Adial Pharmaceuticals Secures Future on Nasdaq: Key $2.5M Equity Requirement Achieved Stock Titan

Revolutionary AI-Powered Phase 3 Trial: How Adial Plans to Transform Alcohol Addiction Treatment Stock Titan

Breakthrough Alcohol Addiction Treatment Heads to Critical FDA Discussion: Adial's Next Big Step Stock Titan

Revolutionary Patent Links Genetic Markers to Personalized Addiction Treatment Success Stock Titan

End of Phase 2 Meeting With the FDA: Adial Prepares to Advance AD04 for Alcohol Use Disorder Psychiatric Times

Senate Committee Votes 26-3 to Support Expanded Drug Trial Metrics: Adial's AUD Treatment Strategy Validated Stock Titan

Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments Yahoo Finance

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update Yahoo Finance

FDA Backs First Genetically-Targeted Alcohol Use Disorder Drug: Adial's AD04 Heads to Phase 3 Stock Titan

Adial Pharmaceuticals Completes Analytical Validation of Cheek Swab Method for AD04 Genetic Testing in Alcohol Use Disorder Treatment Quiver Quantitative

Adial Pharmaceuticals Secures $3.6M Financing: New Shares at $0.32 Plus Warrant Package Stock Titan

Patent Issued for Methods of Identifying Patients With Substance Use-Associated Genetic Markers, Treatment With AD04 Psychiatric Times

AD04 for Alcohol Use Disorder: New Positive Results From Pharmacokinetics Study Psychiatric Times

Positive FDA Feedback for Proposed In Vitro Bridging Strategy for Alcohol Use Disorder Treatment, AD04 Psychiatric Times

Healthcare Investor Commits $2.75M to Adial Pharmaceuticals Addiction Treatment Pipeline Stock Titan

Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement and Reduce the Public Float Yahoo Finance

EXCLUSIVE: Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial Yahoo Finance

FDA Has Granted Request for End of Phase 2 Meeting to Discuss Alcohol Use Disorder Treatment, AD04 Psychiatric Times

Adial Appoints Tony Goodman as Chief Operating Officer citybiz

100% SNP concordance: Adial and Genomind validate cheek‑swab test for AD04; AG+ biomarker ~14% Stock Titan

Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th Yahoo Finance

Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate Stock Titan

Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering citybiz

First Patient Dosed in Pharmacokinetics Study of AD04 for Alcohol Use Disorder Psychiatric Times

Why Is Adial Pharmaceuticals (ADIL) Up 61% Today? InvestorPlace

Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder Benzinga

Why Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today? InvestorPlace

Adial at a clinical fork in the road after flunking phase 3 trial for its alcohol addiction med Fierce Biotech

ADIL - Adial Pharmaceuticals Inc Latest Stock News & Market Updates Stock Titan

ADIL Stock Price and Chart — NASDAQ:ADIL TradingView